Stock Chart

XENE

$41.01 -1.80%
Score: 59.0 HOLD
LEAPs: SELL $55
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $55
Premium: $10.30
Expiry: Dec 18, 2026
Target: $56
Score: -95

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $37.63 - $42.89 UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.44
Vol: 0.57x (vs SPY: 0.4x | vs QQQ: 0.5x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About XENE - Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Key Statistics

Market Cap $3B

This XENE stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track XENE's price movements with trendlines, gamma walls, and key support/resistance levels.